We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

75 hedge funds and large institutions have $22.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 25 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $351K | Put options by funds: $231K

13% less funds holding

Funds holding: 86 → 75 (-11)

28% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 25

30% less capital invested

Capital invested by funds: $32.3M → $22.7M (-$9.61M)

42% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 26

Holders
75
Holders Change
-11
Holders Change %
-12.79%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
18
Reduced
25
Closed
26
Calls
$351K
Puts
$231K
Net Calls
+$120K
Net Calls Change
-$325K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.05M
2
Bank of America
Bank of America
North Carolina
+$704K
3
GCP
GSA Capital Partners
United Kingdom
+$626K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$584K
5
CCM
CAAS Capital Management
New York
+$280K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.13M
2
Millennium Management
Millennium Management
New York
-$1.11M
3
Citadel Advisors
Citadel Advisors
Florida
-$742K
4
BlackRock
BlackRock
New York
-$648K
5
Fisher Asset Management
Fisher Asset Management
Washington
-$425K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
76
Laurion Capital Management
New York
– -$47K -60,619 Closed
Two Sigma Advisers
77
Two Sigma Advisers
New York
– -$38K -48,300 Closed
Balyasny Asset Management
78
Balyasny Asset Management
Illinois
– -$23K -29,524 Closed
YIH
79
Y-Intercept (HK)
Hong Kong
– -$21K -26,513 Closed
V
80
Veritable
Delaware
– -$19K -24,200 Closed
CSS
81
Cubist Systematic Strategies
Connecticut
– -$14K -18,343 Closed
PCM
82
Pinz Capital Management
New York
– -$12K -15,600 Closed
ACM
83
Aquatic Capital Management
Illinois
– -$5K -6,900 Closed
TWM
84
Tradition Wealth Management
Minnesota
– -$4K -5,148 Closed
VCM
85
Versant Capital Management
Arizona
– -$3K -3,838 Closed
Fidelity Investments
86
Fidelity Investments
Massachusetts
– -$2.43K -2,472 -75%
AF
87
Allworth Financial
California
– -$1K -1,140 Closed
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
– -$1K -1,065 Closed
CAPTRUST Financial Advisors
89
CAPTRUST Financial Advisors
North Carolina
– -$1K -845 Closed
PHK
90
Point72 Hong Kong
Hong Kong
– -$1K -817 Closed
Carson Wealth (CWM LLC)
91
Carson Wealth (CWM LLC)
Nebraska
– -$49 -50 -81%
Royal Bank of Canada
92
Royal Bank of Canada
Ontario, Canada
– +$649 +661 +1,437%
1 2 3
4

SPPI Hedge Fund Activity: Q3 2022 in Review

75 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2022, worth a combined $22.7M — down 30% from $32.3M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SPPI and 15 opened new positions — a net loss of 11 holders — while 25 trimmed existing stakes and 18 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.05M. The largest seller was D.E. Shaw & Co, cutting an estimated $4.13M.

  • 75 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2022, down from 86 in Q2 2022.
  • Funds reported $22.7M of Spectrum Pharmaceuticals Inc stock for Q3 2022, down 30% quarter-over-quarter.
  • 15 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2022 and 26 closed out, a net change of -11 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2022 was Acadian Asset Management, an estimated $1.05M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2022 was D.E. Shaw & Co, an estimated $4.13M sold.

Based on aggregated 13F filings for Q3 2022.